The role of the cytochrome P450 system in drug interactions in anaesthesia

Bailliere's Clinical Anaesthesiology

Volumn 12, Issue 2, 1998, Pages 213-228

  Friedericy, H J ^a   Bovill, J G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anaesthesia; Benzodiazepines; Cytochrome P450; Drug interactions; Enzyme induction; Enzyme inhibition; Opioids; Review; Volatile anaesthetics

Indexed keywords

ANESTHETIC AGENT; BENZODIAZEPINE DERIVATIVE; CYTOCHROME P450; INTRAVENOUS ANESTHETIC AGENT; OPIATE; VOLATILE AGENT;

ANALGESIA; ANESTHESIA; ANESTHETIC RECOVERY; AWARENESS; DRUG BLOOD LEVEL; DRUG METABOLISM; ENZYME INDUCTION; ENZYME INHIBITION; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW;

EID: 0031716748     PISSN: 09503501     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-3501(98)80029-9     Document Type: Article

References (83)

1. Ahonen J Olkkola KT Salmenpera M Effect of diltiazem on midazolam and alfentanil disposition in patients undergoing coronary artery bypass grafting Anesthesiology 85 1996 1246 1252
2. Andersson T Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole Clinical Pharmacokinetics 31 1996 9 28
3. Andersson T Miners JO Veronese ME Birkett DJ Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms British Journal of Clinical Pharmacology 38 1994 131 137
4. Andersson T Cederberg C Edvardsson G Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole Clinical Pharmacology and Therapeutics 47 1990 79 85
5. Backman JT Olkkola KT Aranko K Dose of midazolam should be reduced during diltiazem and verapamil treatments British Journal of Clinical Pharmacology 37 1994 221 225
6. Backman JT Olkkola KT Neuvonen PJ Rifampin drastically reduces plasma concentrations and effects of oral midazolam Clinical Pharmacology and Therapeutics 59 1996 7 13
7. Backman JT Olkkola KT Ojala M Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin Epilepsia 37 1996 253 257
8. Bailey DG Spence JD Munoz C Arnold JMO Interactions of citrus juices with felodipine and nifedipine Lancet 337 1991 268 269
9. Bailey DG Arnold MO Strong A Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics Clinical Pharmacology and Therapeutics 54 1993 589 594
10. Baker MT Chadam MV Ronnenberg WCJ Inhibitory effects of propofol on cytochrome P450 activities in rat hepatic microsomes Anesthesia and Analgesia 76 1993 817 821
11. Bartkowski RR McDonnell TE Prolonged alfentanil effect following erythromycin administration Anesthesiology 73 1990 566 568
12. Bartkowski RR Goldberg ME Larijani GE Boerner T Inhibition of alfentanil metabolism by erythromycin Clinical Pharmacology and Therapeutics 46 1989 99 102
13. Bartkowski RR Goldberg ME Huffnagle S Epstein RH Sufentanil disposition. Is it affected by erythromycin administration? Anesthesiology 78 1993 260 265
14. Benedetti MS Inducing properties of rifabutin, and effects on the pharmacokinetics and metabolism of concomitant drugs Pharmacological Research 32 1995 177 187
15. c (abstract) Clinical Pharmacology and Therapeutics 55 1994 146
16. Bertschy G Baumann P Eap CB Baettig D Probable metabolic interaction between methadone and fluvoxamine in addict patients Therapeutic Drug Monitor 16 1994 42 45
17. Bertz RJ Granneman GR Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions Clinical Pharmacokinetics 32 1997 210 258
18. Chen TL Ueng TH Chen SH Human cytochrome P450 mono-oxygenase system is suppressed by propofol British Journal of Anaesthesia 74 1995 558 562
19. Chen TL Wang MJ Huang CH Difference between in vivo and in vitro effects of propofol on defluorination and metabolic activities of hamster hepatic cytochrome P450-dependent mono-oxygenases British Journal of Anaesthesia 75 1995 462 466
20. Feierman DE Identification of cytochrome P450 3A1/2 as the major P450 isoform responsible for the metabolism of fentanyl by rat liver microsomes Anesthesia and Analgesia 82 1996 936 941
21. Feierman DE Lasker JM Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4 Drug Metabolism and Disposition 24 1996 932 939
22. Garton KJ Yuen P Meinwald J Stereoselective metabolism of enflurane by human liver cytochrome P450 2E1 Drug Metabolism and Disposition 23 1995 1426 1430
23. Gascon MP Dayer P In vitro forecasting of drugs which may interfere with the biotransformation of midazolam European Journal of Clinical Pharmacology 41 1991 573 578
24. Gauntlett IS Koblin DD Fahey MR Metabolism of isoflurane in patients receiving isoniazid Anesthesia and Analgesia 69 1989 245 249
25. Gillum JG Israel DS Polk RE Pharmacokinetic drug interactions with antimicrobial agents Clinical Pharmacokinetics 25 1993 450 482
26. Girre C Lucas D Hispard E Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics Biochemical Pharmacology 47 1994 1503 1508
27. Gugler R Jensen JC Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro Gastroenterology 89 1985 1235 1241
28. Hukkinen SK Varhe A Olkkola KT Neuvonen PJ Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice Clinical Pharmacology and Therapeutics 58 1995 127 131
29. Iribarne C Berthou F Baird S Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes Chemical Research in Toxicology 9 1996 365 373
30. Iribarne C Dreano Y Bardou LG Interaction of methadone with substrates of human hepatic cytochrome P450 3A4 Toxicology 117 1997 13 23
31. Janicki PK James MF Erskine WA Propofol inhibits enzymatic degradation of alfentanil and sufentanil by isolated liver microsomes in vitro British Journal of Anaesthesia 68 1992 311 312
32. Kharasch ED Thummel KE Human alfentanil metabolism by cytochrome P450 3A3/4 An explanation for the interindividual variability in alfentanil clearance? Anesthesia and Analgesia 76 1993 1033 1039
33. Kharasch ED Thummel KE Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane Anesthesiology 79 1993 795 807
34. Kharasch ED Hill HF Eddy AC Influence of dexmedetomidine and clonidine on human liver microsomal alfentanil metabolism Anesthesiology 75 1991 520 524
35. Kharasch ED Thummel KE Mautz D Bosse S Clinical enflurane metabolism by cytochrome P450 2E1 Clinical Pharmacology and Therapeutics 55 1994 434 440
36. Kharasch ED Hankins D Mautz D Thummel KE Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis Lancet 347 1996 1367 1371
37. Kharasch ED Russell M Garton K Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe Anesthesiology 87 1997 26 35
38. Kharasch ED Russell M Mautz D The role of cytochrome P450 3A4 in alfentanil clearance: implications for interindividual variability in disposition and perioperative drug interactions Anesthesiology 87 1997 36 50
39. Klotz U Arvela P Rosenkranz B Effect of single doses of cimetidine and ranitidine on the steady-state plasma levels of midazolam Clinical Pharmacology and Therapeutics 38 1985 652 655
40. Kolars JC Schmiedlin-Ren P Schuetz JD Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes Journal of Clinical Investigation 90 1992 1871 1880
41. Kreek MJ Garfield JW Gutjahr CL Giusti LM Rifampin-induced methadone withdrawal New England Journal of Medicine 294 1976 1104 1106
42. Kronbach T Mathys D Umeno M Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4 Molecular Pharmacology 36 1989 89 96
43. Kupferschmidt HH Ha HR Ziegler WH Interaction between grapefruit juice and midazolam in humans Clinical Pharmacology and Therapeutics 58 1995 20 28
44. Labroo RB Thummel KE Kunze KL Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism Drug Metabolism and Disposition 23 1995 490 496
45. Lemberger L Rowe H Bosomworth JC The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam Clinical Pharmacology and Therapeutics 43 1988 412 419
46. Liu SJ Wang RI Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome American Journal of Psychiatry 141 1984 1287 1288
47. Luurila H Olkkola KT Neuvonen PJ Interaction between erythromycin and the benzodiazepines diazepam and flunitrazepam Pharmacology and Toxicology 78 1996 117 122
48. Mazze RI Woodruff RE Heerdt ME Isoniazid-induced enflurane defluorination in humans Anesthesiology 57 1982 5 8
49. von Moltke LL Greenblatt DJ Harmatz JS Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole Journal of Pharmacology and Experimental Therapeutics 276 1996 370 379
50. Murayama N Shimada M Yamazoe Y Distinct effects of phenobarbital and its N-methylated derivative on liver cytochrome P450 induction Archives of Biochemistry and Biophysics 3281 1996 184 192
51. Murray M P450 enzymes Inhibition mechanisms, genetic regulation and effects of liver disease Clinical Pharmacokinetics 23 1992 132 146
52. Nation RL Evans AM Milne RW Pharmacokinetic drug interactions with phenytoin (Part I) Clinical Pharmacokinetics 18 1990 37 60
53. Nation RL Evans AM Milne RW Pharmacokinetic drug interactions with phenytoin (Part II) Clinical Pharmacokinetics 18 1990 131 150
54. Ohnhaus EE Brockmeyer N Dylewicz P Habicht H The effect of antipyrine and rifampin on the metabolism of diazepam Clinical Pharmacology and Therapeutics 42 1987 148 156
55. Olkkola KT Backman JT Neuvonen PJ Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole Clinical Pharmacology and Therapeutics 55 1994 481 485
56. Olkkola KT Ahonen J Neuvonen PJ The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam Anesthesia and Analgesia 82 1996 511 516
57. Olkkola KT Aranko K Luurila H A potentially hazardous interaction between erythromycin and midazolam Clinical Pharmacology and Therapeutics 53 1993 298 305
58. Park BK Kitteringham NR Pirmohamed M Tucker GT Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications British Journal of Clinical Pharmacology 41 1996 477 491
59. Pavlin DJ Coda B Shen DD Effects of combining propofol and alfentanil on ventilation, analgesia, sedation, and emesis in human volunteers Anesthesiology 84 1996 23 37
60. Periti P Mazzei T Mini E Novelli A Pharmacokinetic drug interactions of macrolides Clinical Pharmacokinetics 23 1992 106 131
61. Perucca E Gatti G Cipolla G Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers Clinical Pharmacology and Therapeutics 56 1994 471 476
62. Preskorn SH Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism Clinical Pharmacokinetics 32 supplement 1 1997 S1 S21
63. Raistrick D Hay A Wolff K Methadone maintenance and tuberculosis treatment British Medical Journal 313 1996 925 926
64. Saxon AJ Whittaker S Hawker CS Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases Journal of Clinical Psychiatry 50 1989 228 229
65. Schlanz KD Myre SA Bottorff MB Pharmacokinetic interactions with calcium channel antagonists (Part II) Clinical Pharmacokinetics 21 1991 448 460
66. Shimada T Yamazaki H Mimura M Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians Journal of Pharmacology and Experimental Therapeutics 270 1994 414 423
67. Soons PA Vogels BAPM Roosemalen MCM Grapefruit juice and cimetidine inhibit stereo-selective metabolism of nitrendipine in humans Clinical Pharmacology and Therapeutics 50 1991 394 403
68. Spina E Pisani F Perucca E Clinically significant pharmacokinetic drug interactions with carbamazepine. An update Clinical Pharmacokinetics 31 1996 198 214
69. Spracklin DK Thummel KE Kharasch ED Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4 Drug Metabolism and Disposition 24 1996 976 983
70. Tateishi T Krivoruk Y Ueng YF Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation Anesthesia and Analgesia 82 1996 167 172
71. Tempelhoff R Modica PA Spitznagel ELJ Anticonvulsant therapy increases fentanyl requirements during anaesthesia for craniotomy Canadian Journal of Anaesthesia 37 1990 327 332
72. Thummel KE Kharasch ED Podoll T Kunze K Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1 Drug Metabolism and Disposition 21 1993 350 357
73. Thummel KE O'Shea D Paine MF Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism Clinical Pharmacology and Therapeutics 59 1996 491 502
74. Tong TG Pond SM Kreek MJ Phenytoin-induced methadone withdrawal Annals of Internal Medicine 94 1981 349 351
75. Varhe A Olkkola KT Neuvonen PJ Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole Clinical Pharmacology and Therapeutics 56 1994 601 607
76. Varhe A Olkkola KT Neuvonen PJ Fluconazole but not terbinafine enhances the effects of triazolam by inhibiting its metabolism British Journal of Clinical Pharmacology 41 1996 319 323
77. Varhe A Olkkola KT Neuvonen PJ Diltiazem enhances the effects of triazolam by inhibiting its metabolism Clinical Pharmacology and Therapeutics 59 1996 369 375
78. Venkatesan K Pharmacokinetic drug interactions with rifampicin Clinical Pharmacokinetics 22 1992 47 65
79. Villikka K Kivisto KT Backman JT Triazolam is ineffective in patients taking rifampin Clinical Pharmacology and Therapeutics 61 1997 8 14
80. Warot D Bergougnan L Lamiable D Troleandomycin-triazolam interaction in healthy volunteers: pharmacokinetic and psychometric evaluation European Journal of Clinical Pharmacology 32 1987 389 393
81. Watkins PB Drug metabolism by cytochromes P450 in the liver and small bowel Gastrointestinal Pharmacology 21 1992 511 526
82. Yun CH Wood M Wood AJ Guengerich FP Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance Anesthesiology 77 1992 467 474
83. Zand R Nelson SD Slattery JT Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans Clinical Pharmacology and Therapeutics 54 1993 142 149